Psychiatry & Neurology, Neuromuscular Medicine · Orange, CA
NPI
1356421515
Since 2006
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
200 S. Manchester Avenue Ste. 110, Uci Medical Center
Orange, CA, 92868
Phone (714) 456-2332
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
280 services
Medicare patients, 2024
100
Average age 71
Drug cost, 2024
$2.8M
371 prescriptions
Company payments, 2025
$56K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tahseen Mozaffar was code 99214 (office e&m - established), 103 times for 69 patients. In total Tahseen Mozaffar billed 280 services in 20 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 103 | 69 | $93.49 | $9,630 |
| 94010 Pulmonary Function Testing | Office | 41 | 34 | $13.02 | $534 |
| 99215 Office E&M - Established | Office | 23 | 19 | $141.92 | $3,264 |
| 99205 Office E&M - New | Office | 12 | 12 | $169.47 | $2,034 |
By year: 2022 $21K for 274 services; 2023 $21K for 286 services; 2024 $19K for 280 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 14 | $8.40 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Tahseen Mozaffar prescribed most often to Medicare patients was Pyridostigmine Bromide, with 37 prescriptions and refills. In total Tahseen Mozaffar wrote 371 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pyridostigmine Bromide Generic | 37 | 48 | Under 11 | $2,077 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 34 | 34 | Under 11 | $177K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 32 | 32 | Under 11 | $500K |
| Lumizyme Alglucosidase Alfa | 25 | 25 | Under 11 | $1.4M |
| Radicava Ors Edaravone | 20 | 20 | Under 11 | $268K |
| Gabapentin Generic | 19 | 19 | Under 11 | $308 |
| Mexiletine Hcl Generic | 18 | 26 | Under 11 | $726 |
| Prednisone Generic | 17 | 35 | Under 11 | $362 |
| Methotrexate Methotrexate Sodium | 16 | 29 | Under 11 | $681 |
| Riluzole Generic | 15 | 29 | Under 11 | $1,462 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 15 | 21 | Under 11 | $35K |
| Sodium Chloride 0.9 % Sodium Chloride | 13 | 13 | Under 11 | $67.47 |
| Azathioprine Generic | 13 | 32 | Under 11 | $1,303 |
| Sirolimus Generic | 13 | 29 | Under 11 | $13K |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 13 | 13 | Under 11 | $238K |
Brand drugs: 204 claims; generic drugs: 167 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tahseen Mozaffar $56K ($46K in general payments such as food, travel and fees and $11K for research) from 14 companies. The largest payer was Amicus Therapeutics, Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Amicus Therapeutics, Inc. FOLD | 7 | $17K |
| Genzyme Corporation SNY | 3 | $13K |
| Sarepta Therapeutics, Inc. SRPT | 5 | $11K |
| Argenx US, Inc. ARGX | 19 | $8,072 |
| UCB, Inc. UCB.BR | 5 | $3,719 |
| Amgen Inc. AMGN | 2 | $2,160 |
| BioCryst Pharmaceuticals, Inc. BCRX | 1 | $1,260 |
| Janssen Biotech, Inc. JNJ | 3 | $257 |
| Grifols USA, LLC | 5 | $207 |
| CSL Behring CSL.AX | 1 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.